Feb 02, 2021 2:21pm EST Nexera Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class Conditioning Agent for Hematopoietic Stem Cell Transplantation, Treosulfan, in the United States
Jan 25, 2021 8:30am EST Nexera Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA®
Jan 04, 2021 4:30pm EST Nexera Pharmaceuticals to Present at the SNN Network Canada Virtual Event on Thursday, January 7, 2021
Dec 18, 2020 8:30am EST Nexera Enters into Exclusive License to Register and Commercialize Triamcinolone Hexacetonide (TH) in the United States with Ethypharm
Dec 08, 2020 8:30am EST Nexera to Present at The 13th Annual LD Micro Main Event Conference on December 15th
